Quantification of receptor interactions using binding methods

Journal of Receptor and Signal Transduction Research

Volumn 21, Issue 2-3, 2001, Pages 139-165

  Lazareno, Sebastian ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BINDING AFFINITY; DRUG RECEPTOR BINDING; QUANTITATIVE ASSAY; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION;

BINDING SITES; BINDING, COMPETITIVE; MATHEMATICS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; RECEPTORS, DRUG;

EID: 0035177413     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.1081/RRS-100107426     Document Type: Review

References (51)

1. What are the criteria in ligand-binding studies for use in receptor classification?
2. Strategy and tactics in receptor-binding studies
3. Radioligand-binding methods: Practical guide and tips
4. The problems and pitfalls of radioligand-binding
5. 50) of an enzymatic reaction
6. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (m1), cardiac (m2), and pancreatic (m3) muscarinic receptors
7. The kinetics of competitive radioligand-binding predicted by the law of mass action
8. Intracellular trafficking of the muscarinic acetylcholine receptor: Importance of subtype and cell type
9. d estimates related to tissue concentration in ligand-binding assays using filtration
10. Gel-filtration sssays for solubilised receptors
11. Methods in binding studies
12. The use of the filtration technique in in vitro radioligand-binding assays for membrane bound and solubilized receptors
13. Centfifugation binding assays
14. The effects of saponin on the binding and functionfil properties of the human adenosine a1 receptor
15. Somatostatin receptors in neuro2a neuroblastoma cells: Operational characteristics
16. Characterization of a 5-ht(1b) receptor on cho cells: Functional responses in the absence of radioligand-binding
17. Recent progress in identifying nicotinic receptors in mammalian brain
18. Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain
19. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
20. Presence of alpha-cobratoxin and phospholipase a2 activity in thymopoietin preparations
21. Binding of insulin and other hormones to non-receptor materials: Saturability, specificity and apparent "negative cooperativity"
22. Overview of neurotransmitter receptor binding
23. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
24. Interpretation of binding curves obtained with high receptor concentrations: Practical aid for computer analysis
25. 3h]bradykinin dissociates slowly
26. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor
27. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model
28. Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system
29. The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium
30. Assessment of a ternary model for the binding of agonists to neurohumoral receptors
31. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis
32. Interactions of ergot alkaloids with anterior pituitary d-2 dopamine receptors
33. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptidel receptors: Evidence for multiple receptor states
34. Reverse intrinsic activity of antagonists on g protein-coupled receptors
35. Antagonists of bradykinin that stabilize a g-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells
36. Agonist-independent inhibition of g protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes
37. Constitutively active 5-hydroxytryptamine 2C receptors reveal novel inverse agonist activity of receptor ligands
38. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor
39. The classification of seven transmembrane receptors in recombinant expression systems
40. Receptor conformational induction versus selection: All part of the same energy landscape
41. Constitutive activation of muscarinic receptors by the G-protein Gq
42. Affinity, efficacy, and receptor classification: Is the classical theory still useful?
43. Negative Antagonists Promote an Inactive Conformation of the Beta 2-adrenergic Receptor
44. Constitutive activation of a single effector pathway: Evidence for multiple activation states of a g protein-coupled receptor
45. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: Thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits